Red Cat Holdings, Inc. (BIT:1RCAT)

Market Cap	800.95M
Revenue (ttm)	2.12M
Net Income (ttm)	-75.65M
Shares Out	n/a
EPS (ttm)	-0.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	413
Open	7.60
Previous Close	7.60
Day's Range	7.60 - 7.60
52-Week Range	6.04 - 10.45
Beta	n/a
RSI	49.70
Earnings Date	Jul 25, 2025

About Ligand Pharmaceuticals

Red Cat Holdings, Inc., together with its subsidiaries, provides products and solutions to drone industry in the United States. The company offers research and development of software solutions such as cloud-based analytics, storage, and services. It also resells drones and related parts; sells consumer electronics products; sophisticated and complex unmanned aerial vehicle UAV technology to military, government and commercial operations. In addition, the company provides VTOL drone, sensor and software solutions. Red Cat Holdings, Inc. is base...

• Industry: Aircraft
• CEO: Jeffrey Thompson
• Employees: 115
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1RCAT

Financial Performance

In 2024, Red Cat Holdings's revenue was $7.28 million, a decrease of -59.21% compared to the previous year's $17.84 million. Losses were -$65.42 million, 172.0% more than in 2024.